Answers are grounded in this paper and cite their sources.
Objective: To observe the efficacy of ultrasound-guided multi-site injection for treating rotator cuff injury combined with shoulder adhesive capsulitis. Methods: Sixty patients diagnosed clinically and radiologically were randomly divided into two groups: the three-site injection group (T group, 30 cases) involving the glenohumeral joint cavity, subacromial bursa, and rotator cuff interval, and the two-site injection group (B group, 30 cases) involving the glenohumeral joint cavity and the long head of the biceps tendon sheath. Visual analogue scale (VAS), University of California, Los Angeles (UCLA) shoulder score, and active range of motion (AROM) of the shoulder joint were observed before treatment and at 1 week, 1 month, and 3 months after treatment. Results: Both groups showed significant improvement in VAS, UCLA scores, and AROM after treatment compared to baseline (P < 0.05). At all follow-up time points, the T group showed significantly better VAS and UCLA scores than the B group (P < 0.05). At 1 week after treatment, no significant difference was observed in shoulder flexion between the two groups (P > 0.05), but the T group showed significantly better shoulder abduction and external rotation compared to the B group (P < 0.05). At 1 month and 3 months post-injection, the T group exhibited significantly better improvements in shoulder flexion, abduction, and external rotation compared to the B group (P < 0.05). Conclusion: Both ultrasound-guided injection protocols effectively improve shoulder joint function and mobility and reduce pain in patients with rotator cuff injury combined with shoulder adhesive cap-sulitis. However, the three-site injection protocol demonstrated superior effi-cacy.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: